The spread of monkeypox (monkeypox) is seen to be getting more violent over time with 70 countries recording positive cases so far.
Worsening the situation further when the World Health Organization (WHO) announced the disease as a global emergency, in line with the current situation of the Covid-19 pandemic.
Following that, investors may place themselves in the health and recovery themed sector which is seen as a 'golden hole' considering the focus is on containing it rather than becoming a pandemic.
Here are some of the stocks of vaccine or antivirus and virus tracker companies that are in focus, among them:
Nordic Bavarians
The Danish biotech company saw its shares jump 3-fold after the government ordered additional monkepox vaccinations at the end of May.
In fact, Citigroup Inc is seen raising its price target (TP) on the company at 20% and predicts more hikes based on the situation.
Siga Technologies
This vaccine or antivirus company, Toxx, has seen its production increase 2 times this year.
It is understood that the vaccine produced by this company has been approved in the United States (US), Europe and the United Kingdom (UK).
Emergent BioSolutions Inc and Tembexa Chimerix Inc
These two companies have collaborated in selling the ACAM2000 Emergent vaccine, a smallpox vaccine that can be used against monkeypox.
KM Biologics
This unit of Meiji Holdings Co has begun researching a monkeypox vaccine in Japan, with the company's shares jumping 12% in June.
Precision System
The Japanese medical test kit manufacturer has seen its shares double since June following the spread of monkeypox in the sun-drenched country.
Autobio Diagnostics Co, Shanghai ZJ Bio-Tech Co and Daan Gene Co. Shanghai ZJ, 3 out of 30 virus testing kit manufacturers in China, saw their shares jump 40% in July.
Antigen and antibody test kit manufacturer Zhejiang Orient Gene Biotech Coand Assure Tech (Hangzhou) Co is seen as another potential beneficiary in China.
